Value analysis of sequential combination therapy of Kangfu anti-inflammatory suppository and azithromycin for acute pelvic inflammatory disease
康妇消炎栓和阿奇霉素序贯联合治疗急性盆腔炎的价值分析

摘要

目的 评估康妇消炎栓和阿奇霉素序贯联合治疗急性盆腔炎的价值。方法 于2023年12月至2024年12月期间，从收治的患者中筛选出80例急性盆腔炎病例，并运用随机数字表法将其均分为两组，对照组给予阿奇霉素常规治疗，观察组在对照组基础上联合康妇消炎栓序贯治疗。通过系统观察与数据分析，对两组临床治疗效果、症状体征缓解时长，以及血清炎症因子水平进行了全面比较。结果 观察组总有效率高于对照组，腹痛、发热、白带异常、盆腔包块消失时间均短于对照组，CRP、IL-6、TNF-α水平低于对照组（p＜0.05）。结论 康妇消炎栓与阿奇霉素序贯联合治疗急性盆腔炎，能够显著提升治疗效果，并有效减轻体内炎症反应，且安全性良好，值得进一步推广。

Abstract

Objective To evaluate the value of sequential combination therapy of Kangfu anti-inflammatory suppository and azithromycin for acute pelvic inflammatory disease.
Methods From December 2023 to December 2024, 80 cases of acute pelvic inflammatory disease were selected from the admitted patients and randomly divided into two groups using a random number table. The control group received conventional treatment with azithromycin, while the observation group received sequential treatment with Kangfu anti-inflammatory suppositories in addition to the control group. Through systematic observation and data analysis, a comprehensive comparison was made between the two groups in terms of clinical treatment efficacy, duration of symptom relief, and serum inflammatory cytokine levels.
Results The total effective rate of the observation group was higher than that of the control group, and the disappearance time of abdominal pain, fever, abnormal vaginal discharge, and pelvic mass was shorter than that of the control group. The levels of CRP, IL-6, and TNF - α were lower than those of the control group (p<0.05).
Conclusion   The sequential combination therapy of Kangfu anti-inflammatory suppository and azithromycin can significantly improve the treatment effect of acute pelvic inflammatory disease, effectively reduce the inflammatory response in the body, and has good safety, which is worthy of further promotion.